Celebrating 25 Years of Scoop
Special: Up To 25% Off Scoop Pro Learn More
Parliament

Gordon Campbell | Parliament TV | Parliament Today | Video | Questions Of the Day | Search

 

Up To 12,000 Severe Allergy Sufferers To Benefit From EpiPen Funding

Today the Government welcomes news that yet another important medicine will be fully funded due to a major increase in the budget of the national medicines-buying agency Pharmac.

“The decision by Pharmac to fully fund the EpiPen brand of adrenaline auto injectors will be life changing for thousands of New Zealanders,” Health Minister Andrew Little said.

The EpiPen brand of adrenaline auto injectors will be available for people who have previously experienced a severe allergic reaction, known as anaphylaxis, or people at significant risk from 1 February 2023.

“It is expected that there will be around 12,000 people accessing adrenaline auto-injectors in the first year of funding, increasing to 17,000 people per year after five years.

“This decision will make a considerable difference to people’s lives and that of their whānau and caregivers.

“The Government’s increase in the pharmaceuticals budget since 2017 has enabled Pharmac to fund 70 new medicines and widen access to over 130, with more to come,” Andrew Little said.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Parliament Headlines | Politics Headlines | Regional Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 
 

InfoPages News Channels


 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.